News
European Commission grants marketing approval for Teva’s DuoResp Spiromax
Teva Pharmaceutical has obtained marketing authorisation approval from European Commission for its DuoResp Spiromax for treatment of patients with asthma and chronic obstructive pulmonary...
News
Janssen’s type 2 diabetes drug Vokanamet gets European Commission approval in EU
Janssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU) as a treatment for...
News
Bavarian Nordic doses first patient in Phase II trial of CV-301 to treat bladder cancer
Denmark-based biotechnology firm Bavarian Nordic has dosed first patient in a randomised, prospective Phase II trial of its active immunotherapy product candidate CV-301 for...
Press Releases
Azbil Telstar Opens New Subsidiary in Bangladesh and Reinforces Leading Position in Asia
Telstar has enhanced its global activities in engineering and construction for local and multinational pharmaceutical companies The ability to offer comprehensive...
Press Releases
DNA Electronics Secures Funding From Genting Berhad To Develop Genalysis® Point-of-Care Genomic Diagnostics Product Line
DNA Electronics Ltd (DNAe), a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it had successfully secured the necessary...
News
NICE recommends afatinib for treatment of lung cancer
The National Institute for Health and Care Excellence (NICE) in the UK has issued its final health technology appraisal recommending afatinib as a first-line...
News
Alexion begins multinational registration trials of eculizumab to treat NMO and MG
US-based Alexion Pharmaceuticals has started a single, multinational, placebo-controlled trial designed to assess the safety and efficacy of eculizumab (Soliris) in patients with relapsing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read